Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol
- PMID: 11044428
- DOI: 10.1161/01.cir.102.17.2105
Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol
Abstract
Background: The clinical usefulness of adriamycin is restricted by the development of congestive heart failure. It has been suggested that probucol, a strong antioxidant, completely prevents adriamycin-induced cardiomyopathy without interfering with its antitumor properties. The present study investigated the effects of adriamycin and probucol on myocardial antioxidant enzyme activities and immunoreactive protein levels in rats.
Methods and results: Activities and protein levels of glutathione peroxidase (GSHPx) were significantly decreased from 2 to 24 hours, and those of manganese superoxide dismutase were decreased at 1 and 2 hours after adriamycin treatment. These changes were prevented by probucol. Catalase activity was increased from 2 to 24 hours after adriamycin treatment, but its protein levels were not significantly changed. Copper zinc superoxide dismutase activity and protein level were not changed at any time. Myocardial lipid peroxidation was found to be significantly higher at all time points, and this change was also prevented by probucol. Treatment with probucol alone increased GSHPx activity at 2 weeks, and in these hearts, lipid peroxidation was lower than the control value. Within 24 hours, there was no mortality in any of the groups.
Conclusions: It is suggested that an early and persistent decrease in GSHPx activity and protein may play an important role in the pathogenesis of adriamycin-induced cardiomyopathy, worsening heart failure and mortality.
Similar articles
-
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin.Mol Cell Biochem. 2002 Mar;232(1-2):19-26. doi: 10.1023/a:1014862912783. Mol Cell Biochem. 2002. PMID: 12030376
-
Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats.Cardiovasc Res. 2000 Jun;46(3):523-30. doi: 10.1016/s0008-6363(00)00039-0. Cardiovasc Res. 2000. PMID: 10912462
-
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.Circulation. 1994 Jun;89(6):2829-35. doi: 10.1161/01.cir.89.6.2829. Circulation. 1994. PMID: 8205698
-
Combination therapy with probucol prevents adriamycin-induced cardiomyopathy.J Mol Cell Cardiol. 1995 Apr;27(4):1055-63. doi: 10.1016/0022-2828(95)90074-8. J Mol Cell Cardiol. 1995. PMID: 7563102 Review.
-
Adriamycin-induced heart failure: mechanism and modulation.Mol Cell Biochem. 2000 Apr;207(1-2):77-86. doi: 10.1023/a:1007094214460. Mol Cell Biochem. 2000. PMID: 10888230 Review.
Cited by
-
Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.J Pharmacol Exp Ther. 2015 Nov;355(2):272-9. doi: 10.1124/jpet.115.225490. Epub 2015 Sep 9. J Pharmacol Exp Ther. 2015. PMID: 26354996 Free PMC article.
-
Early changes in myocardial antioxidant enzymes in rats treated with adriamycin.Mol Cell Biochem. 2002 Mar;232(1-2):19-26. doi: 10.1023/a:1014862912783. Mol Cell Biochem. 2002. PMID: 12030376
-
TBP-associated factor 1 overexpression induces tolerance to Doxorubicin in confluent H9c2 cells by an increase in cdk2 activity and cyclin E expression.Mol Cell Biochem. 2004 Apr;259(1-2):71-81. doi: 10.1023/b:mcbi.0000021347.65073.10. Mol Cell Biochem. 2004. PMID: 15124910
-
Vitamin C: historical perspectives and heart failure.Heart Fail Rev. 2021 May;26(3):699-709. doi: 10.1007/s10741-020-10036-y. Epub 2020 Oct 8. Heart Fail Rev. 2021. PMID: 33033908 Review.
-
Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis.Cancers (Basel). 2022 Jan 28;14(3):683. doi: 10.3390/cancers14030683. Cancers (Basel). 2022. PMID: 35158951 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical